CRISPR Excitement

Researchers and drug companies are enthusiastic about the use of genome editing tools like CRISPR-Cas9 to replace disease-causing genetic variants with healthy DNA stretches, the Wall Street Journal reports.

It cautions that therapies based on such approaches won't be available for years, if at all, but adds that they offer "tremendous potential for new treatments."

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The New York Times and ProPublica say that many physicians fail to disclose their financial ties when publishing in medical journals.

The Wall Street Journal reports Human Longevity's valuation has dropped by 80 percent.

Science reports that the US National Cancer Institute is cutting its operating budget by 5 percent.

In PLOS this week: similar variants seen in bullbogs, people with Robinow syndrome; ApoE genotypes in African-American, Puerto Rican populations; and more.